Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30.2M
-
Number of holders
-
207
-
Total 13F shares, excl. options
-
13.2M
-
Shares change
-
+417K
-
Total reported value, excl. options
-
$412M
-
Value change
-
+$14.2M
-
Put/Call ratio
-
0.77
-
Number of buys
-
89
-
Number of sells
-
-87
-
Price
-
$31.22
Significant Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q1 2023
250 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 207 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.2M shares
of 30.2M outstanding shares and own 43.67% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.65M shares), VANGUARD GROUP INC (1.38M shares), DIMENSIONAL FUND ADVISORS LP (854K shares), STATE STREET CORP (799K shares), GEODE CAPITAL MANAGEMENT, LLC (405K shares), Divisadero Street Capital Management, LP (367K shares), Invesco Ltd. (366K shares), MORGAN STANLEY (303K shares), CITADEL ADVISORS LLC (298K shares), and AMERICAN CENTURY COMPANIES INC (278K shares).
This table shows the top 207 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.